Minotaur

Minotaur is a cognitive and performance-enhancing amino formulation designed to support both mental focus and physical endurance.

Educational summaryAmino formulation reference

(how we review)

Reported protocols for Minotaur

What published studies and recent community write-ups report about amounts, timing and course length. 5 clinical, 1 preclinical and 2 community-reported rows, each linked to its source. These are descriptions of what others report, not instructions, and nothing here is medical advice.

ContextDoseFrequencyRouteCourseSource
Clinical5 rows
Ingredient: citicoline, randomized trial in older adults100 healthy adults aged 50-85 with age-associated memory impairment500 mgOnce dailyOral capsules12 weeksNot applicableThe Journal of Nutrition (PubMed)2021
Episodic memory and a composite memory score improved more on citicoline than on placebo, with no product-related adverse events. The primary outcome (spatial span) did not differ, the trial was funded by the ingredient's manufacturer, and 500 mg a day by mouth is about eleven times the citicoline in 1 mL of the blend.
Ingredient: betaine (TMG), randomized trial in strength-trained men23 experienced strength-trained men (11 betaine, 12 placebo)2.5 g per day (1.25 g twice daily)Twice dailyOral capsules6 weeks of periodized trainingNot applicableJournal of the International Society of Sports Nutrition (PubMed)2013
Betaine improved body composition, arm size and bench-press work capacity and blunted the training-related rise in urinary homocysteine thiolactone, but did not change one-repetition strength. Twenty-three men over six weeks is a small trial, and the 30 mg of TMG per mL of Minotaur is less than 2% of this daily dose.
Ingredient: L-citrulline versus L-arginine, crossover exercise trial10 healthy adult men6 g per day of citrulline or of arginineDaily, tested on days 6 and 7Oral7 days per supplement, placebo-controlled crossoverNot applicableJournal of Applied Physiology (PubMed)2015
Seven days of citrulline lowered blood pressure, sped oxygen-uptake kinetics and lengthened time to exhaustion in severe cycling from 589 to 661 seconds, while the same dose of arginine changed none of these despite raising plasma arginine by a similar amount. The trial used daily gram doses in ten men; Minotaur supplies 50 mg of citrulline and 200 mg of arginine per mL.
Ingredient: L-arginine, FDA label for the intravenous diagnostic productAdults weighing 60 kg or more undergoing growth hormone reserve testing30 g arginine hydrochloride (300 mL of a 10% solution); 0.5 g/kg in lighter patientsSingle infusion per testIntravenous infusion over 30 minutesOne testNot applicableDailyMed, National Library of Medicine2024
The only approved injectable arginine is a diagnostic infusion used to provoke growth hormone release for testing, and its label states it is not intended for therapeutic use and warns of fatal metabolic acidosis from pediatric overdose. Community claims that the blend's arginine drives pumps or growth hormone rest on this kind of gram-level infusion, not on 200 mg injected into a muscle.
Ingredient: tyrosine, review of human cognition studiesHealthy adults under stress or cognitive load, and clinical populations, across the reviewed trials100-150 mg/kg, or 2 g, as single doses in most positive studies; 500 mg to 12 g across all studiesSingle dose before a stressor or task in most trialsOralAcute in most studiesNot applicableJournal of Psychiatric Research (PubMed)2015
The 2015 review concludes that tyrosine helps working memory and cognitive control only when catecholamines are being depleted by stress or demanding tasks, and finds little support for benefit in physical exercise or in clinical disorders. It covers plain L-tyrosine; the blend uses the acetylated form at 35 mg per mL, roughly 2% of the smallest effective single dose in the review.
Preclinical1 row
Ingredient: L-norvaline, arginase inhibition in ratsMale Wistar rats with drug-induced nitric oxide deficiency, 10 per group10 mg/kgOnce dailyIntraperitoneal injection7 daysNot applicableInternational Journal of Hypertension (PubMed Central)2011
L-norvaline brought the coefficient of endothelial dysfunction back toward normal in rats whose nitric oxide synthesis had been blocked with L-NAME or methionine loading, consistent with its role as an arginase inhibitor. This is the kind of animal work behind the claim that norvaline prolongs arginine's effect; no human trial of norvaline was found.
Sources for this section (9)
  1. Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialThe Journal of Nutrition (PubMed)2021Clinical
  2. Effects of betaine on body composition, performance, and homocysteine thiolactoneJournal of the International Society of Sports Nutrition (PubMed)2013Clinical
  3. l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humansJournal of Applied Physiology (PubMed)2015Clinical
  4. R-GENE 10 (arginine hydrochloride injection): Prescribing InformationDailyMed, National Library of Medicine2024Clinical
  5. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: A reviewJournal of Psychiatric Research (PubMed)2015Clinical
  6. Arginase Inhibitor in the Pharmacological Correction of Endothelial DysfunctionInternational Journal of Hypertension (PubMed Central)2011Preclinical

Plus 3 community resources (dosing guides, forum threads and vendor write-ups), reported above but not linked.

Overview

Minotaur is a vendor-made, ready-to-use injectable blend marketed as a pre-workout and nootropic: betaine (TMG), CDP-choline, L-arginine, N-acetyl-L-tyrosine, L-norvaline, L-lysine and L-citrulline in a 20 mL vial. The legacy sheet lists 1 mL three to five times a week, about 45 minutes before training, and sketches a two-week crossover pilot design, but gives no amounts per millilitre; a vendor listing of the same formulation (sold as MNT or Minotaur Power) and a 2025 storage guide both put it at 30 mg TMG, 45 mg citicoline, 200 mg arginine, 35 mg NALT, 35 mg norvaline, 50 mg lysine and 50 mg citrulline per mL in water with 1% benzyl alcohol. No study has tested the blend; the human evidence below concerns individual ingredients taken by mouth at gram-level daily doses, norvaline has only animal data, and the product has no regulatory approval.

What researchers are exploring

These themes organize the educational information currently available. Individual claims remain under source review and are not treatment claims.

  • 1

    TMG (Betaine)

    Acts as a methyl donor, supporting liver health and homocysteine regulation. Molecular Formula: C 5 H 11 NO 2 Molecular Weight: 117.15 g/mol

  • 2

    CDP-Choline

    Involved in acetylcholine synthesis and brain membrane repair. Molecular Formula: C 14 H 26 N 4 O 11 P 2 Molecular Weight: 488.32 g/mol

  • 3

    L-Arginine

    Precursor for nitric oxide synthesis; supports blood flow and vascular tone. Molecular Formula: C 6 H 14 N 4 O 2 Molecular Weight: 174.20 g/mol

  • 4

    N-Acetyl-L-Tyrosine (NALT)

    Precursor to dopamine, aiding focus and motivation under stress. Molecular Formula: C 11 H 13 NO 4 Molecular Weight: 223.22 g/mol

  • 5

    Norvaline

    Inhibits arginase, prolonging arginine’s NO-enhancing effects. Molecular Formula: C 5 H 11 NO 2 Molecular Weight: 117.15 g/mol

  • 6

    Lysine

    Contributes to collagen formation and immune defense. Molecular Formula: C 6 H 14 N 2 O 2 Molecular Weight: 146.19 g/mol

What is known and what still needs verification

Available context is organized without assigning unsupported study models or evidence grades.

  • Not graded

    TMG (Betaine)

    Acts as a methyl donor, supporting liver health and homocysteine regulation. Molecular Formula: C 5 H 11 NO 2 Molecular Weight: 117.15 g/mol

  • Not graded

    CDP-Choline

    Involved in acetylcholine synthesis and brain membrane repair. Molecular Formula: C 14 H 26 N 4 O 11 P 2 Molecular Weight: 488.32 g/mol

Limitations and unknowns

Important limitations

  • Individual claims and source links have not yet completed editorial verification.
  • Evidence level, applicable study model, formulation, route and population remain unassigned.

Sources

1 link carried over from the earlier page, awaiting verification.

  1. Source link (pmc.ncbi.nlm.nih.gov)Verification pendingNot graded